新疆医科大学学报
新疆醫科大學學報
신강의과대학학보
JOURNAL OF XINJIANG MEDICAL UNIVERSITY
2014年
4期
419-426
,共8页
娜祖科·库尔班塔依%巴吐尔·买买提明%买吾拉尼江·依孜布拉%Denise Dubrovin%哈木拉提·吾甫尔
娜祖科·庫爾班塔依%巴吐爾·買買提明%買吾拉尼江·依孜佈拉%Denise Dubrovin%哈木拉提·吾甫爾
나조과·고이반탑의%파토이·매매제명%매오랍니강·의자포랍%Denise Dubrovin%합목랍제·오보이
异常黑胆质证%哮喘%代谢组学%核磁共振%大鼠尿液
異常黑膽質證%哮喘%代謝組學%覈磁共振%大鼠尿液
이상흑담질증%효천%대사조학%핵자공진%대서뇨액
metabonomics%Abnormal Savda Syndrome%NMR%asthma%rat urine
目的:探讨维药异常黑胆质成熟剂对异常黑胆质型支气管哮喘大鼠尿液代谢物变化的影响。方法应用多因素复合作用建立异常黑胆质证载体动物模型,采用卵清蛋白(OVA)致敏和雾化激发方法建立异常黑胆质型支气管哮喘病证模型,将SD大鼠(84只)随机分为空白对照组、异常黑胆质证载体模型组、异常黑胆质证型支气管哮喘模型组、异常黑胆质成熟剂给药组(分为大、中、小剂量组)、地塞米松给药阳性对照组。收集各组大鼠尿液,利用核磁共振波谱(1 H -NMR)技术测定核磁共振氢谱,建立大鼠尿液的代谢指纹谱,运用正交偏最小二乘判别分析(OPLS -DA)法分析各组大鼠尿液中代谢产物差异。结果与空白对照组相比,异常黑胆质型哮喘模型组柠檬酸、肌酸酐、甘氨酸等重要氨基酸含量降低,差异有统计学意义(P <0.05);灌胃异常黑胆质成熟剂之后,异常黑胆质型哮喘模型组降低的肌酸酐及乙酸等含量明显增高,牛磺酸、甜菜碱等含量降低,与异常黑胆质型哮喘模型组比较差异有统计学意义(P <0.05);与异常黑胆质型哮喘模型组相比,地塞米松给药阳性对照组马尿酸、乳酸、丙氨酸等含量升高(P <0.05)。结论异常黑胆质成熟剂对异常黑胆质型哮喘大鼠代谢具有显著影响,其作用机制可能是通过作用于异常黑胆质型支气管哮喘大鼠体内氨基酸代谢与能量代谢途径而发挥预防及治疗异常黑胆质型支气管哮喘的作用。
目的:探討維藥異常黑膽質成熟劑對異常黑膽質型支氣管哮喘大鼠尿液代謝物變化的影響。方法應用多因素複閤作用建立異常黑膽質證載體動物模型,採用卵清蛋白(OVA)緻敏和霧化激髮方法建立異常黑膽質型支氣管哮喘病證模型,將SD大鼠(84隻)隨機分為空白對照組、異常黑膽質證載體模型組、異常黑膽質證型支氣管哮喘模型組、異常黑膽質成熟劑給藥組(分為大、中、小劑量組)、地塞米鬆給藥暘性對照組。收集各組大鼠尿液,利用覈磁共振波譜(1 H -NMR)技術測定覈磁共振氫譜,建立大鼠尿液的代謝指紋譜,運用正交偏最小二乘判彆分析(OPLS -DA)法分析各組大鼠尿液中代謝產物差異。結果與空白對照組相比,異常黑膽質型哮喘模型組檸檬痠、肌痠酐、甘氨痠等重要氨基痠含量降低,差異有統計學意義(P <0.05);灌胃異常黑膽質成熟劑之後,異常黑膽質型哮喘模型組降低的肌痠酐及乙痠等含量明顯增高,牛磺痠、甜菜堿等含量降低,與異常黑膽質型哮喘模型組比較差異有統計學意義(P <0.05);與異常黑膽質型哮喘模型組相比,地塞米鬆給藥暘性對照組馬尿痠、乳痠、丙氨痠等含量升高(P <0.05)。結論異常黑膽質成熟劑對異常黑膽質型哮喘大鼠代謝具有顯著影響,其作用機製可能是通過作用于異常黑膽質型支氣管哮喘大鼠體內氨基痠代謝與能量代謝途徑而髮揮預防及治療異常黑膽質型支氣管哮喘的作用。
목적:탐토유약이상흑담질성숙제대이상흑담질형지기관효천대서뇨액대사물변화적영향。방법응용다인소복합작용건립이상흑담질증재체동물모형,채용란청단백(OVA)치민화무화격발방법건립이상흑담질형지기관효천병증모형,장SD대서(84지)수궤분위공백대조조、이상흑담질증재체모형조、이상흑담질증형지기관효천모형조、이상흑담질성숙제급약조(분위대、중、소제량조)、지새미송급약양성대조조。수집각조대서뇨액,이용핵자공진파보(1 H -NMR)기술측정핵자공진경보,건립대서뇨액적대사지문보,운용정교편최소이승판별분석(OPLS -DA)법분석각조대서뇨액중대사산물차이。결과여공백대조조상비,이상흑담질형효천모형조저몽산、기산항、감안산등중요안기산함량강저,차이유통계학의의(P <0.05);관위이상흑담질성숙제지후,이상흑담질형효천모형조강저적기산항급을산등함량명현증고,우광산、첨채감등함량강저,여이상흑담질형효천모형조비교차이유통계학의의(P <0.05);여이상흑담질형효천모형조상비,지새미송급약양성대조조마뇨산、유산、병안산등함량승고(P <0.05)。결론이상흑담질성숙제대이상흑담질형효천대서대사구유현저영향,기작용궤제가능시통과작용우이상흑담질형지기관효천대서체내안기산대사여능량대사도경이발휘예방급치료이상흑담질형지기관효천적작용。
Objective To study the effect of Abnormal Savda Munziq on urine metabolic changes of Abnor-mal Savda Syndrome carrying asthma rat model .Methods Multiple factors was used to establish Abnor-mal Savda rat model ,according to the Traditional Uyghur Medicine .By sensitization and challenge with ovalbumin (OVA) Abnormal Savda Syndrome carrying rat model was established further .84 SD rats were randomly divided into black control group ,Abnormal Savda Syndrome control group ,Abnormal Savda Syndrome carrying asthma control group ,Munziq group (respectively ,low dose ,middle dose and high dose group) and Dexamethasone (DXM ) group .Nuclear Magnetic Resonance Spectroscopy (1 H-NMR) technique was used for determination of collected urine ,metabolic fingerprints of rat urine was estab-lished ,and orthogonal to partial least squares discriminant analysis (OPLS-DA) method was used for the analysis of differences among metabolites in urine from all goups .Results Various kinds of amino acids from Abnormal Savda Syndrome carrying asthma control group are markedly lower ,including citric acid , glycine ,creatinine ,compared to black control group ,and the differences were statistically significant (P<0 .05);Afrer oral administration of Abnormal Savda M unziq ,creatinine ,acetic acid in Abnormal Savda Syndrome carrying asthma rat urine increased ,and taurine ,betaine were reduced ,compared with Abnor-mal Savda Syndrome carrying asthma control group ,the differences were statistically significant (P <0 .05) .Compared with Abnormal Savda Syndrome carrying asthma control group ,hippuric acid ,lactic acid , alanine were higher in dexamethasone group ,and the differences were statistically significant (P <0 .05) . Conclusion Abnormal Savda Munziq has significant effects on Abnormal Savda Syndrome carrying asthma rat urine metabolites ,the mechanism of w hich may achieved by readjusting the altered amino acid metabo-lism and energy metabolism caused by Abnormal Savda Syndrome carrying asthma .